Pridinol oral
- Drugs List
- Therapeutic Indications
- Dosage
- Administration
- Contraindications
- Precautions and Warnings
- Pregnancy and Lactation
- Side Effects
- Monograph
Presentation
Oral formulations of pridinol.
Drugs List
Therapeutic Indications
Uses
Muscle spasms
Central and peripheral muscle spasms: lumbar pain, torticollis and general muscle pain.
Dosage
Adults
1.5mg to 3mg, three times daily.
Administration
Take independently of meals. The onset of the effect of pridinol is faster when taken prior to meals.
Take pridinol with at least one glass of water. Do not chew.
Contraindications
Children under 18 years
Benign prostatic hyperplasia
Breastfeeding
Cardiac arrhythmias
First trimester of pregnancy
Galactosaemia
Gastrointestinal obstruction
Glaucoma
Urinary retention
Precautions and Warnings
Elderly
Glucose-galactose malabsorption syndrome
Hypotension
Lactose intolerance
Second trimester of pregnancy
Severe hepatic impairment
Severe renal impairment
Third trimester of pregnancy
Advise ability to drive/operate machinery may be affected by side effects
Contains lactose
Patients who suffer from hypotension are at greater risk of circulatory problems. These patients should take pridinol after meals to reduce the risk of fainting.
Pregnancy and Lactation
Pregnancy
Pridinol is contraindicated during the first trimester of pregnancy.
Use of pridinol during the first trimester of pregnancy is contraindicated by the manufacturer. The manufacturer does not recommend using pridinol during the further course of pregnancy unless absolutely necessary and under medical supervision. At the time of writing there is limited published information regarding the use of pridinol during pregnancy. Potential risks are unknown.
Lactation
Pridinol is contraindicated during breastfeeding.
Use of pridinol when breastfeeding is contraindicated by the manufacturer. The presence of pridinol in human breast milk and the effects on exposed infants are unknown.
Side Effects
Abdominal pain
Anxiety
Arrhythmias
Asthenia
Attention disturbances
Bradycardia
Circulatory collapse
Depression
Diarrhoea
Disturbances in accommodation
Dizziness
Dry mouth
Dyspnoea
Erythema
Fatigue
Feeling hot
Glaucoma (closed angle)
Hallucinations
Headache
Hypersensitivity reactions
Hypotension
Impaired vision
Micturition disorders
Muscle weakness
Muscular coordination disorders
Nausea
Oedema
Paraesthesia
Pruritus
Restlessness
Speech disturbances
Tachycardia
Taste disturbances
Thirst
Tremor
Urinary retention
Vomiting
Overdosage
It is strongly recommended that the UK National Poisons Information Service be consulted on cases of suspected or actual overdose where there is doubt over the degree of risk or about appropriate management.
The following number will direct the caller to the relevant local centre (0844) 892 0111
Information may be obtained if you have access to ToxBase the primary clinical toxicology database of the National Poisons Information Service. This is available via password on the internet ( www.toxbase.org ) or if this is unavailable at the backup site ( www.toxbasebackup.org ).
Further Information
Last Full Review Date: November 2020
Reference Sources
Summary of Product Characteristics: Myopridin 3mg tablets. Mibe Pharma UK Ltd. Revised May 2020.
Medscape UK | Univadis prescription drug monographs & interactions are based on FDB Multilex Content
FDB Disclaimer : FDB Multilex is intended for the use of healthcare professionals and is provided on the basis that the healthcare professionals will retain FULL and SOLE responsibility for deciding what treatment to prescribe or dispense for any particular patient or circumstance.